New formulation is dispersible and strawberry-flavored, enabling the youngest children living with HIV to be treated with the best available medication New price agreement with Viatris and Macleods will significantly lower cost for yearly pediatric HIV...
A long-awaited HIV treatment designed specifically for children will now be available in low-and middle-income countries, thanks to a landmark agreement from Unitaid and CHAI. The new pricing agreement with generic manufacturers Viatris and Macleods means a new...
This webinar, recorded Nov. 12, 2020, highlights key HIV market trends in low- and middle-income countries, based on CHAI’s annual market report, as well as a panel discussion focusing on what comes next as the global community grapples with both HIV and...
Antimicrobial resistance (AMR) is a global public health threat. Every year, a growing number of bacteria, viruses, fungi, and parasites become resistant to existing medications, making common infections harder to treat and increasing the risk of disease transmission,...
